ARMC
GNOM icon

American Research & Management Company’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

American Research & Management Company’s Portfolio GNOM Stock Details GNOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$2K Hold
38
– – ﹤0.01% 379
2022
Q2 		$2K Hold
38
– – ﹤0.01% 367
2022
Q1 		$2K Buy
+38
New +$2.4K ﹤0.01% 377

Other funds holding GNOM

Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management Milwaukee, Wisconsin $187B AUM 21.7% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return
MIG
McGuire Investment Group Wakefield, Rhode Island $1.14B AUM 79.59% 1-Year Est. Return
OCM
One Capital Management Westlake Village, California $3.6B AUM 16.02% 1-Year Est. Return
PGA
Portland Global Advisors Portland, Maine $1.05B AUM 18.22% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return

American Research & Management Company's GNOM Position: Q3 2022 in Review

American Research & Management Company held its Global X Genomics & Biotechnology ETF (GNOM) position steady in Q3 2022 at 38 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #379.

American Research & Management Company first reported a position in GNOM in Q1 2022 and has held it in 3 quarters since. 59 funds tracked by Wall St. Rank hold GNOM as of Q3 2022.

  • American Research & Management Company held 38 shares of Global X Genomics & Biotechnology ETF worth $2K as of Q3 2022.
  • American Research & Management Company left its Global X Genomics & Biotechnology ETF share count unchanged in Q3 2022.
  • Global X Genomics & Biotechnology ETF made up ﹤0.01% of American Research & Management Company's portfolio in Q3 2022, its #379 holding.
  • American Research & Management Company first reported a position in Global X Genomics & Biotechnology ETF in Q1 2022 and has held it in 3 quarters since.
  • 59 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q3 2022.

Based on American Research & Management Company's 13F filing for Q3 2022, filed 7 Oct 2022.